277 related articles for article (PubMed ID: 12853461)
1. Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism.
Pelicano H; Feng L; Zhou Y; Carew JS; Hileman EO; Plunkett W; Keating MJ; Huang P
J Biol Chem; 2003 Sep; 278(39):37832-9. PubMed ID: 12853461
[TBL] [Abstract][Full Text] [Related]
2. Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents.
Zhou Y; Hileman EO; Plunkett W; Keating MJ; Huang P
Blood; 2003 May; 101(10):4098-104. PubMed ID: 12531810
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide.
Iwama K; Nakajo S; Aiuchi T; Nakaya K
Int J Cancer; 2001 May; 92(4):518-26. PubMed ID: 11304686
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity.
Hileman EO; Liu J; Albitar M; Keating MJ; Huang P
Cancer Chemother Pharmacol; 2004 Mar; 53(3):209-19. PubMed ID: 14610616
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia.
Cai X; Shen YL; Zhu Q; Jia PM; Yu Y; Zhou L; Huang Y; Zhang JW; Xiong SM; Chen SJ; Wang ZY; Chen Z; Chen GQ
Leukemia; 2000 Feb; 14(2):262-70. PubMed ID: 10673743
[TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells.
Woo SH; Park IC; Park MJ; Lee HC; Lee SJ; Chun YJ; Lee SH; Hong SI; Rhee CH
Int J Oncol; 2002 Jul; 21(1):57-63. PubMed ID: 12063550
[TBL] [Abstract][Full Text] [Related]
7. ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells.
Gu S; Chen C; Jiang X; Zhang Z
Chem Biol Interact; 2016 Feb; 245():100-9. PubMed ID: 26772155
[TBL] [Abstract][Full Text] [Related]
8. Involvement of mitochondrial aggregation in arsenic trioxide (As2O3)-induced apoptosis in human glioblastoma cells.
Haga N; Fujita N; Tsuruo T
Cancer Sci; 2005 Nov; 96(11):825-33. PubMed ID: 16271077
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells.
Ramos AM; Fernández C; Amrán D; Sancho P; de Blas E; Aller P
Blood; 2005 May; 105(10):4013-20. PubMed ID: 15665116
[TBL] [Abstract][Full Text] [Related]
10. The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells.
Kang YH; Lee SJ
J Cell Physiol; 2008 Oct; 217(1):23-33. PubMed ID: 18412143
[TBL] [Abstract][Full Text] [Related]
11. Phloretin ameliorates arsenic trioxide induced mitochondrial dysfunction in H9c2 cardiomyoblasts mediated via alterations in membrane permeability and ETC complexes.
Vineetha VP; Soumya RS; Raghu KG
Eur J Pharmacol; 2015 May; 754():162-72. PubMed ID: 25746422
[TBL] [Abstract][Full Text] [Related]
12. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines.
Sánchez Y; Simón GP; Calviño E; de Blas E; Aller P
J Pharmacol Exp Ther; 2010 Oct; 335(1):114-23. PubMed ID: 20605902
[TBL] [Abstract][Full Text] [Related]
13. Combination treatment with arsenic trioxide and phytosphingosine enhances apoptotic cell death in arsenic trioxide-resistant cancer cells.
Park MT; Kang YH; Park IC; Kim CH; Lee YS; Chung HY; Lee SJ
Mol Cancer Ther; 2007 Jan; 6(1):82-92. PubMed ID: 17237268
[TBL] [Abstract][Full Text] [Related]
14. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13.
Merkel O; Heyder C; Asslaber D; Hamacher F; Tinhofer I; Holler C; Stöcher M; Prokesch A; Papak C; Scheideler M; Trajanoski Z; Greil R
J Mol Med (Berl); 2008 May; 86(5):541-52. PubMed ID: 18297255
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ
J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107
[TBL] [Abstract][Full Text] [Related]
17. Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-C.
Pelicano H; Carew JS; McQueen TJ; Andreeff M; Plunkett W; Keating MJ; Huang P
Leukemia; 2006 Apr; 20(4):610-9. PubMed ID: 16482209
[TBL] [Abstract][Full Text] [Related]
18. The role of mitochondrial targeting in arsenic trioxide-induced apoptosis in myeloid cell lines.
Körper S; Nolte F; Thiel E; Schrezenmeier H; Rojewski MT
Br J Haematol; 2004 Jan; 124(2):186-9. PubMed ID: 14687028
[TBL] [Abstract][Full Text] [Related]
19. JWA is required for arsenic trioxide induced apoptosis in HeLa and MCF-7 cells via reactive oxygen species and mitochondria linked signal pathway.
Zhou J; Ye J; Zhao X; Li A; Zhou J
Toxicol Appl Pharmacol; 2008 Jul; 230(1):33-40. PubMed ID: 18387645
[TBL] [Abstract][Full Text] [Related]
20. Pro-oxidant mitochondrial matrix-targeted ubiquinone MitoQ10 acts as anti-oxidant at retarded electron transport or proton pumping within Complex I.
Plecitá-Hlavatá L; Jezek J; Jezek P
Int J Biochem Cell Biol; 2009; 41(8-9):1697-707. PubMed ID: 19433311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
